C162H226F3N19O12 — CID 158670281
2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide (PubChem CID 158670281) has the molecular formula C162H226F3N19O12 and a molecular weight of 2688.70 g/mol. Its IUPAC name is 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide.
| Compound Name | 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide |
|---|---|
| PubChem CID | 158670281 |
| Molecular Formula | C162H226F3N19O12 |
| Molecular Weight | 2688.70 g/mol |
| Exact Mass | 2686.76 |
| IUPAC Name | 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide |
| SMILES | CC(C)C[C@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.CC(C)[C@@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.Cc1ccc(CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccc3ccccc23)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2ccccc2C(F)(F)F)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccnc2)CC1 |
| InChI | InChI=1S/C29H37N3O2.C29H43N3O2.C28H41N3O2.C26H34F3N3O2.C26H37N3O2.C24H34N4O2/c33-27(18-29-15-21-12-22(16-29)14-23(13-21)17-29)30-19-28(34)32-10-8-31(9-11-32)20-25-6-3-5-24-4-1-2-7-26(24)25;1-21(2)12-26(28(34)32-10-8-31(9-11-32)20-22-6-4-3-5-7-22)30-27(33)19-29-16-23-13-24(17-29)15-25(14-23)18-29;1-20(2)26(27(33)31-10-8-30(9-11-31)19-21-6-4-3-5-7-21)29-25(32)18-28-15-22-12-23(16-28)14-24(13-22)17-28;27-26(28,29)22-4-2-1-3-21(22)17-31-5-7-32(8-6-31)24(34)16-30-23(33)15-25-12-18-9-19(13-25)11-20(10-18)14-25;1-19-2-4-20(5-3-19)18-28-6-8-29(9-7-28)25(31)17-27-24(30)16-26-13-21-10-22(14-26)12-23(11-21)15-26;29-22(14-24-11-19-8-20(12-24)10-21(9-19)13-24)26-16-23(30)28-6-4-27(5-7-28)17-18-2-1-3-25-15-18/h1-7,21-23H,8-20H2,(H,30,33);3-7,21,23-26H,8-20H2,1-2H3,(H,30,33);3-7,20,22-24,26H,8-19H2,1-2H3,(H,29,32);1-4,18-20H,5-17H2,(H,30,33);2-5,21-23H,6-18H2,1H3,(H,27,30);1-3,15,19-21H,4-14,16-17H2,(H,26,29)/t;23?,24?,25?,26-,29?;22?,23?,24?,26-,28?;;;/m.01.../s1 |
| InChIKey | IDWDNUXCDFFQRM-VOMGHKOXSA-N |
| XLogP | 22.64 |
| TPSA | 328.79 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 196 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2688.70 |
| LogP ≤ 5 | 22.64 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 19 |